Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Combretastatin A-4 phosphate (...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Combretastatin A-4 phosphate (CA4P) carboplatin and paclitaxel in patients with platinum-resistant ovarian cancer: Final phase II trial results
Bibliographic Details
Main Authors:
Zweifel, M
,
Jayson, G
,
Reed, N
,
Osborne, R
,
Hassan, B
,
Shreeves, G
,
Poupard, L
,
Walicke, P
,
Balkissoon, J
,
Chaplin, D
,
Rustin, G
Format:
Conference item
Published:
2009
Holdings
Description
Similar Items
Staff View
Description
Summary:
Similar Items
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer.
by: Zweifel, M, et al.
Published: (2011)
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer.
by: Rustin, G, et al.
Published: (2010)
A phase I study of combretastatin A4 phosphate (CA4P) and bevacizumab in subjects with advanced solid tumors
by: Nathan, P, et al.
Published: (2008)
Phase IB dose-escalation and expansion study of AKT kinase inhibitor afuresertib with carboplatin and paclitaxel in recurrent platinum-resistant ovarian cancer
by: Blagden, S, et al.
Published: (2018)
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer.
by: Nathan, P, et al.
Published: (2012)